Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Liabilities and Shareholders Equity: 2009-2012

Historic Liabilities and Shareholders Equity for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $357.8 million.

  • Lexicon Pharmaceuticals' Liabilities and Shareholders Equity rose 21.42% to $357.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $1.6 billion, marking a year-over-year increase of 19.02%. This contributed to the annual value of $430.5 million for FY2011, which is 17.34% up from last year.
  • As of Q3 2012, Lexicon Pharmaceuticals' Liabilities and Shareholders Equity stood at $357.8 million, which was down 6.09% from $381.1 million recorded in Q2 2012.
  • In the past 5 years, Lexicon Pharmaceuticals' Liabilities and Shareholders Equity registered a high of $430.5 million during Q4 2011, and its lowest value of $223.7 million during Q3 2009.
  • Its 3-year average for Liabilities and Shareholders Equity is $367.1 million, with a median of $366.9 million in 2010.
  • In the last 5 years, Lexicon Pharmaceuticals' Liabilities and Shareholders Equity spiked by 67.40% in 2010 and then fell by 20.54% in 2011.
  • Lexicon Pharmaceuticals' Liabilities and Shareholders Equity (Quarterly) stood at $257.8 million in 2009, then skyrocketed by 42.33% to $366.9 million in 2010, then rose by 17.34% to $430.5 million in 2011, then grew by 21.42% to $357.8 million in 2012.
  • Its Liabilities and Shareholders Equity was $357.8 million in Q3 2012, compared to $381.1 million in Q2 2012 and $402.8 million in Q1 2012.